NASDAQ
6.68USD
+0.31 (+4.87%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.1B
P/E
—
EPS
—
Beta
1.19
52W range
2.711-7.3
Day range
6.28–6.75
Open
6.42
Prev close
6.37
Volume
5M
Avg volume
3M
Dividend
0.00
IPO
2020-09-24
https://seekingalpha.com/article/4935110-taysha-gene-therapies-inc-tsha-q2-2026-earnings-call-transcript · 8/12/2026+0.00
https://www.globenewswire.com/news-release/2026/06/25/3317255/0/en/Taysha-Gene-Therapies-Announces-Pricing-of-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html · 6/25/2026-0.20
https://seekingalpha.com/article/4916763-taysha-gene-therapies-inc-tsha-discusses-longer-term-clinical-data-and-program-update-for · 6/22/2026+0.40
https://www.defenseworld.net/2026/03/21/taysha-gene-therapies-q4-earnings-call-highlights.html · 3/21/2026+0.20
https://www.globenewswire.com/news-release/2025/10/09/3164079/0/en/Taysha-Gene-Therapies-Presents-New-Supplemental-Data-Analysis-from-Part-A-of-the-REVEAL-Phase-1-2-Trials-for-TSHA-102-in-Rett-Syndrome-at-the-54th-CNS-Annual-Meeting.html · 10/9/2025+1.00
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
